Viewing Study NCT02992860

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:06 AM
Ignite Modification Date: 2026-03-02 @ 8:19 AM
Study NCT ID: NCT02992860
Status: TERMINATED
Last Update Posted: 2018-10-25
First Post: 2016-12-12
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Single Agent JNJ-56022473 in MDS and AML Patients FAILING HYPOMETHYLATING AGENT BASED THERAPY
Sponsor: GWT-TUD GmbH
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelodysplastic Syndrome (MDS) View
None Acute Myeloid Leukemia (AML) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Myelodysplastic Syndrome (MDS) View
None Acute Myeloid Leukemia (AML) View
None hypomethylating agent (HMA) treatment View
None leukemic stem cell View
None CD123 View
None immunotherapy View